You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 8,562,978


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,562,978
Title:Stable digestive enzyme compositions
Abstract: Compositions of the present invention, comprising at least one digestive enzyme (e.g., pancrelipase) are useful for treating or preventing disorders associated with digestive enzyme deficiencies. The compositions of the present invention can comprise a plurality of coated particles, each of which is comprised of a core coated with an enteric coating comprising at least one enteric polymer and 4-10% of at least one alkalinizing agent, or have moisture contents of about 3% or less, water activities of about 0.6 or less, or exhibit a loss of activity of no more than about 15% after six months of accelerated stability testing.
Inventor(s): Ortenzi; Giovanni (Monza, IT), Marconi; Marco (Cinisello Balsamo, IT), Mapelli; Luigi (Milan, IT)
Assignee: Aptalis Pharma Limited (Wicklow, IE)
Application Number:12/832,596
Patent Claims: 1. A pancrelipase composition comprising a plurality of coated particles, each of which is comprised of a core coated with an enteric coating; wherein the core comprises pancrelipase, at least one disintegrant, and at least one polymeric binder, and the enteric coating comprises at least one enteric polymer and 4-10 wt. % of at least one alkalinizing agent, based on the total weight of the composition.

2. The composition of claim 1, wherein said composition has a moisture content of about 3% or less.

3. The composition of claim 1, wherein said composition has a moisture content of about 2% or less.

4. The composition of claim 1, wherein said composition has a water activity of about 0.6 or less.

5. The composition of claim 1, wherein the at least one disintegrant is croscarmellose sodium, the at least one polymeric binder is microcrystalline cellulose, the enteric polymer is hydroxypropylmethylcellulose phthalate, and the alkalinizing agent is talc.

6. The composition of claim 1, wherein the core further comprises one or more excipients selected from the group consisting of plasticizers, glidants, lubricants, and combinations thereof, and the coating further comprises at least one plasticizer.

7. The composition of claim 6, wherein the core further comprises hydrogenated castor oil, colloidal silicon dioxide, and magnesium stearate; and the coating further comprises triethyl citrate.

8. The composition of claim 1, wherein the core comprises 60-90 wt. % of pancrelipase, 1-4 wt. % of at least one disintegrant, and 2-6 wt. % of at least one polymeric binder, based on the total weight of the composition.

9. The composition of claim 8, wherein the disintegrant is croscarmellose sodium, and the polymeric binder is microcrystalline cellulose.

10. The composition of claim 1, wherein the coating comprises 10-20 wt. % of hydroxypropylmethylcellulose phthalate, based on the total weight of the composition.

11. The composition of claim 1, wherein the core comprises: 60-90 wt. % of pancrelipase; 1-4 wt. % of at least one disintegrant; 0.5-1.0 wt. % of at least one plasticizer; 0.2-0.6 wt. % of at least one glidant; 2-6 wt. % of at least one polymeric binder; 0.2-0.6 wt. % of at least one lubricant; the coating comprises: 10-20 wt. % of at least one enteric polymer; 4-10 wt. % of at least one alkalinizing agent; and 1-2 wt. % of at least one plasticizer, based on the total weight of the composition.

12. The composition of claim 11, wherein the at least one disintegrant is croscarmellose sodium, the at least one plasticizer of the core is hydrogenated castor oil, the at least one polymeric binder is microcrystalline cellulose, the at least one lubricant is magnesium stearate, the at least one enteric polymer is hydroxypropylmethylcellulose phthalate, the at least one alkalinizing agent is talc, and the at least one plasticizer of the coating is triethyl citrate.

13. A capsule filled with the plurality of coated particles of claim 1, wherein the capsule has a moisture content of less than about 4%.

14. A capsule filled with the plurality of coated particles of claim 1, wherein the capsule has a moisture content of less than about 2%.

15. A capsule filled with the plurality of coated particles of claim 11, wherein the capsule has a moisture content of less than about 4%.

16. A capsule filled with the plurality of coated particles of claim 11, wherein the capsule has a moisture content of less than about 2%.

17. A capsule comprised of hydroxypropylmethylcellulose filled with the plurality of coated particles of claim 1.

18. A capsule comprised of hydroxypropylmethylcellulose filled with the plurality of coated particles of claim 11.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.